Creative Diagnostic Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 77.53%
- Profit Growth 168.96%
- Ebitda 135.36%
- Net Worth 49.34%
- Total Assets 49.35%
About Creative Diagnostic Medicare
Creative Diagnostic Medicare Private Limited (CDMPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 June 2003 and has a history of 21 years and eight months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deoman Tripathi, Sushant Karekar, and Vishwas Karekar serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2003PTC140840
-
Company No.
140840
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jun 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Creative Diagnostic Medicare Private Limited offer?
Creative Diagnostic Medicare Private Limited offers a wide range of products and services, including Testing & Measuring Equipments, Test Kits, Rapid Test Kit, Diagnostic Test Kit.
Who are the key members and board of directors at Creative Diagnostic Medicare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deoman Tripathi
|
Director | 11-Jun-2003 | Current |
|
Sushant Karekar
|
Director | 09-Sep-2022 | Current |
|
Vishwas Karekar
|
Director | 11-Jun-2003 | Current |
Financial Performance of Creative Diagnostic Medicare.
Creative Diagnostic Medicare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 77.53% increase. The company also saw a substantial improvement in profitability, with a 168.96% increase in profit. The company's net worth Soared by an impressive increase of 49.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Creative Diagnostic Medicare?
In 2019, Creative Diagnostic Medicare had a promoter holding of 82.70% and a public holding of 17.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Creative Diagnostic Medicare?
Unlock and access historical data on people associated with Creative Diagnostic Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Creative Diagnostic Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Creative Diagnostic Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
